Former OpenAI Chief Scientist Alleges CEO Sam Altman Engaged in Dishonesty
Former OpenAI executive Sutskever says he spent a year gathering proof of alleged Altman dishonesty
The Economic TimesImage: The Economic Times
Ilya Sutskever, former chief scientist of OpenAI, testified that he spent a year gathering evidence of CEO Sam Altman's alleged dishonesty, which included undermining executives. This testimony is part of a legal battle involving OpenAI and co-founder Elon Musk, who seeks $150 billion in damages and the removal of Altman.
- 01Ilya Sutskever testified he collected evidence of Sam Altman's dishonesty over a year.
- 02Sutskever expressed regret over his role in Altman's firing and later voted for his reinstatement.
- 03Elon Musk is pursuing $150 billion in damages from OpenAI and its backer Microsoft.
- 04Sutskever revealed discussions about a potential merger with rival Anthropic.
- 05Microsoft CEO Satya Nadella described the company's investment in OpenAI as a calculated risk.
Advertisement
In-Article Ad
Ilya Sutskever, the former chief scientist of OpenAI, testified in a California courtroom that he spent approximately one year compiling evidence of CEO Sam Altman's alleged dishonesty. Sutskever indicated that Altman exhibited a 'consistent pattern of lying' and undermined other executives, prompting discussions about his removal from the CEO position. Sutskever had prepared a 52-page document detailing these claims at the request of OpenAI's board. His testimony is part of a legal dispute involving Elon Musk, who is seeking $150 billion in damages from OpenAI and its major investor, Microsoft, alleging that the company has strayed from its nonprofit roots. Musk has demanded the removal of Altman and President Greg Brockman from their roles. Sutskever also disclosed that his ownership stake in OpenAI is valued at around $7 billion and mentioned that after Altman's brief ouster, there were discussions about merging OpenAI with rival Anthropic. Microsoft CEO Satya Nadella characterized the tech giant's investment in OpenAI as a 'calculated risk' during the trial. The closing arguments are set for Thursday, as the trial continues to unfold.
Advertisement
In-Article Ad
The outcome of this trial could significantly influence the future direction of OpenAI and its leadership, affecting employees and investors.
Advertisement
In-Article Ad
Reader Poll
Do you believe corporate leaders should be held accountable for dishonesty?
Connecting to poll...
More about OpenAI
Read the original article
Visit the source for the complete story.



